Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer at Procter & Gamble Co, filed a Form 4 on August 24, 2026, disclosing the sale of 3,053 shares of common stock on August 19, 2026.

Key Highlights

  • Reporting person: Moses Victor Javier Aguilar, identified as Chief Research, Development & Innovation Officer of Procter & Gamble Co (NYSE:PG).
  • Shares disposed: 3,053 shares of common stock sold on August 19, 2026, at $143.79 per share.
  • Purpose of sale: According to the filing, shares were "sold to cover taxes on Stock Award."
  • Direct ownership following transaction: 49,511.0935 shares held directly after the reported transaction.
  • Indirect holdings: 7,476.1294 shares held indirectly via a Retirement Plan Trustee, and 428.6033 shares held indirectly via an International Stock Ownership Plan (Mexico) Trustee.
  • Signed: Wednesday Shipp, attorney-in-fact for Mr. Aguilar Moses, signed the filing on August 24, 2026.

Procter & Gamble R&D Officer Reports Tax-Related Share Sale

According to the Form 4 filed with the SEC on August 24, 2026, Moses Victor Javier Aguilar, serving as Chief Research, Development & Innovation Officer at Procter & Gamble Co (NYSE:PG), disposed of 3,053 shares of common stock on August 19, 2026. The filing notes the transaction code as "S" (a sale), with the shares disposed of at a price of $143.79 each. The filing's footnote states the shares were "sold to cover taxes on Stock Award," indicating the transaction was a tax-withholding event rather than a discretionary open-market sale.

Following the transaction, the filing reports that Aguilar directly holds 49,511.0935 shares of Procter & Gamble common stock. In addition to his direct holdings, the filing discloses two categories of indirect beneficial ownership: 7,476.1294 shares held by a Retirement Plan Trustee, and 428.6033 shares held by an International Stock Ownership Plan (Mexico) Trustee.

The Form 4 was signed by Wednesday Shipp as attorney-in-fact for Mr. Aguilar Moses and submitted on August 24, 2026. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The filing discloses a sale of 3,053 shares of Procter & Gamble common stock at $143.79 per share by the company's Chief R&D Officer on August 19, 2026, attributed to tax coverage on a stock award, with resulting direct ownership of 49,511.0935 shares.